# Increased nucleotide metabolism alleviates Alzheimer’s disease pathology

## TL;DR

Boosting nucleotide metabolism may help reduce DNA damage and slow the progression of Alzheimer's disease.

## Contribution

The study identifies a metabolic signature in Alzheimer's and shows that enhancing nucleotide metabolism can protect against AD pathology.

## Key findings

- Higher PARP1 levels in AD neurons correlate with increased disease risk and somatic mutations.
- AD animals show decreased phosphorylated nucleotides, and boosting nucleotide metabolism protects against AD.
- Higher DGUOK expression is linked to a lower risk of developing Alzheimer's disease.

## Abstract

Genetic information in cells flows from DNA to RNA to proteins, which form molecular machines. During normal ageing, cell intrinsic and environmental factors alter this flow of information by damaging DNA in cells, including postmitotic neurons. Damage to DNA is associated with age-related neurodegenerative diseases such as Alzheimer’s disease (AD). We previously reported an increase in DNA repair mechanisms in a fly model of AD. However, the causal mechanisms underlying somatic mutations in AD remain unclear. Here, we combine in silico methods from single-cell genomics of patients with AD with experimental validation in a Drosophila model of AD to elucidate the DNA repair processes in AD. We show that the levels of poly(ADP‒ribose) polymerase 1 (PARP1), which mediates multiple DNA damage repair pathways, are increased in the brains of patients with AD. We found that higher PARP1 levels in neurons from patients with AD are linked to increased disease risk and a greater burden of somatic mutations. Nucleotide imbalance can increase the frequency of somatic mutations upon activation of DNA repair processes. Using a fly model of AD, we identified a metabolic signature in AD animals characterised by decreased levels of phosphorylated nucleotides. Enhancing nucleotide metabolism via dietary supplementation or genetic manipulation protects against AD pathology in animals. Finally, Mendelian randomisation revealed that higher expression of human deoxyguanosine kinase (DGUOK) is linked to a lower risk of developing AD. Our results suggest that enhancing nucleotide metabolism could improve DNA repair and serve as an adjunct therapy to delay AD progression.